巨细胞依赖葡萄糖载体1 (GLUT1) 和GLUT3进行IgE介导的激活
Mirjana Grujic1, Md Abdul Alim2,3,4, Lars Hellman5
1Uppsala University, Department of Medical Biochemistry and Microbiology, Uppsala, Sweden.
Inflammation
|April 2, 2024
概括
巨细胞 (MCs) 依赖葡萄糖载体GLUT1和GLUT3进行IgE介导的激活. 抑制这些载体会减少MC脱粒和细胞因子的释放,这表明对过敏症的潜在治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 代谢过程中的代谢.
背景情况:
- 乳腺母细胞 (MCs) 在过敏反应中起着关键作用.
- 有限的证据表明MCs和糖尿病之间存在联系,但葡萄糖对MCs的直接影响尚不清楚.
- 由MCs表达的特定葡萄糖载体及其在MC激活中的作用尚不清楚.
研究的目的:
- 为了研究高葡萄糖度是否直接影响巨细胞.
- 为了识别由巨细胞表达的葡萄糖载体.
- 为了确定乳腺细胞是否依赖葡萄糖载体来激活.
主要方法:
- 对乳腺细胞进行了分析,以检测葡萄糖载体的表达.
- 进行了GLUT1和GLUT3葡萄糖载体的抑制.
- 测量了对IgE受体交叉连接和48/80化合物的巨细胞反应.
- 评估了细胞活力和对葡萄糖升高的反应.
主要成果:
- 巨细胞表达高水平的葡萄糖载体1 (GLUT1) 和葡萄糖载体3 (GLUT3).
- 单独或联合抑制GLUT1或GLUT3,显著降低IgE受体介导的脱粒和细胞因子的产生.
- 联合抑制GLUT1和GLUT3对IgE介导反应产生了更明显的影响.
- 抑制GLUT1或GLUT3对对48/80化合物的反应的影响很小.
- 葡萄糖水平升高并没有影响MC活力或对任何激活方法的反应.
结论:
- 乳腺细胞高度依赖通过GLUT1和/或GLUT3运输葡萄糖,以获得最佳的IgE介导激活.
- 较高的葡萄糖水平对乳腺细胞功能的影响很小.
- GLUT1和GLUT3抗剂代表了过敏症的潜在治疗药物.
相关概念视频
Glucose Absorption Into the Small Intestine
31.6K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
31.6K
Immunoglobulin-like Cell Adhesion Molecules
3.3K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.3K
Glucose Transporters
22.7K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.7K
GPCRs Regulate Adenylyl Cylase Activity
5.5K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.5K
cAMP-dependent Protein Kinase Pathways
6.3K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.3K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
288
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
288


